Abstract Submission

• Abstracts must be original and should not have been published elsewhere or submitted for publication in any Journal.
• All abstracts must be in English
• Please indicate whether the abstract is for Oral or Poster Presentation.
• All abstracts have to be in structured format – IMRaD (Introduction, Material and Method, Result and Discussion).
• You may submit as many abstracts as you like, however, each presenter will be limited to only one presentation
• Only one presenting author is allowed per abstract
• Presenting author of the abstract must be a registered participant. Presenting author’s Registration is a must to ensure the abstract is included in the Congress Book and in order to be scheduled for presentation.
• Submission of an abstract acknowledges your acceptance for the abstract to be published in the official Congress Book.
• We encourage you to submit your full manuscripts (complete paper including illustrations).
• All submissions will be reviewed by the Congress Scientific Committee. The Authors will then be notified by email.
• Copyright transfer will be requested if the paper is chosen for Journal publication.
• If you have any queries, please contact us at info@cleft2016icpf.com
• Last date for submission of abstracts – 1st September 2016
• Last date for notification of abstract acceptance – 25th September 2016

Abstract Guidelines

• Authors are required to specify the category of their topic.
• Authors can upload their works in MS Word or PDF format, illustrations in JPEG, GIF or TIFF formats.
• Each abstract must be a completed study, following the stated outline, and as extensive as possible to permit accurate review.
• No. of words: Abstracts- 250-300 Full Manuscript- 1500-2000
• Incomplete abstracts cannot be evaluated and therefore, cannot be accepted.
• Abstracts should include Authors’ Affiliation details – department, institution / hospital, city, state, country, email, full postal address, telephone and mobile number
• All abbreviations used must be clearly defined.
• References must be included.
• Drugs must be identified by their generic names.